Patents by Inventor David Robert Greaves

David Robert Greaves has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cannabinoid-2-Receptor Agonists
    Publication number: 20140378451
    Abstract: The present invention relates to cannabinoid-2-receptor (CB2R) agonist compounds. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them and to their use as therapeutic agents for the treatment and/or prevention of diseases or conditions in which CB2R stimulation is beneficial (especially inflammatory conditions).
    Type: Application
    Filed: September 19, 2012
    Publication date: December 25, 2014
    Inventors: Ivy Christou, Rebecca Lillian Cross, Matteo Gianella-Borradori, David Robert Greaves, Angela Jane Russell, Graham Michael Wynne
  • Gene expression in monocytes and macrophages
    Publication number: 20030138411
    Abstract: The invention provides a cloned polynucleotide having the function of a transcriptional regulatory sequence (trs) and comprising: (a) a polynucleotide fragment having at least 70% identity to the polynucleotide of SEQ ID NO.:2; (b) a polynucleotide which is complementary to the polynucleotide of (a); or (c) a polynucleotide comprising at least 15 sequential bases of the polynucleotide of (a) or (b).
    Type: Application
    Filed: February 1, 2002
    Publication date: July 24, 2003
    Applicant: Glaxo Wellcome Inc.
    Inventor: David Robert Greaves